BR9707266A - Compostos dihidrobenzofurano úteis como agentes antiinflamatórios - Google Patents
Compostos dihidrobenzofurano úteis como agentes antiinflamatóriosInfo
- Publication number
- BR9707266A BR9707266A BR9707266A BR9707266A BR9707266A BR 9707266 A BR9707266 A BR 9707266A BR 9707266 A BR9707266 A BR 9707266A BR 9707266 A BR9707266 A BR 9707266A BR 9707266 A BR9707266 A BR 9707266A
- Authority
- BR
- Brazil
- Prior art keywords
- atoms
- branched
- straight
- cyclic alkyl
- hydrogen
- Prior art date
Links
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical class C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 title 1
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 125000004429 atom Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/595,086 US5672620A (en) | 1996-02-01 | 1996-02-01 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| PCT/US1997/001316 WO1997028148A1 (en) | 1996-02-01 | 1997-01-30 | Dihydrobenzofuran compounds useful as anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9707266A true BR9707266A (pt) | 1999-04-13 |
Family
ID=24381674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9707266A BR9707266A (pt) | 1996-02-01 | 1997-01-30 | Compostos dihidrobenzofurano úteis como agentes antiinflamatórios |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5672620A (pt) |
| EP (1) | EP0891346B1 (pt) |
| JP (1) | JP3095425B2 (pt) |
| KR (1) | KR100322403B1 (pt) |
| CN (1) | CN1120838C (pt) |
| AT (1) | ATE266652T1 (pt) |
| AU (1) | AU730310B2 (pt) |
| BR (1) | BR9707266A (pt) |
| CA (1) | CA2244196C (pt) |
| DE (1) | DE69729083T2 (pt) |
| DK (1) | DK0891346T3 (pt) |
| ES (1) | ES2221034T3 (pt) |
| MX (1) | MX9806252A (pt) |
| NO (1) | NO983531L (pt) |
| WO (1) | WO1997028148A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319944B1 (en) * | 1999-05-10 | 2001-11-20 | Merck & Co., Inc. | Aryl amidines, compositions containing such compounds and methods of use |
| US20030129186A1 (en) | 2001-07-25 | 2003-07-10 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| GB0503672D0 (en) * | 2005-02-23 | 2005-03-30 | Astrazeneca Ab | New process |
| CN101287411B (zh) | 2005-04-28 | 2013-03-06 | 普罗秋斯生物医学公司 | 药物信息系统及其用途 |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| EP2641903B1 (de) | 2012-03-19 | 2014-10-22 | Symrise AG | Dihydrobenzofuran-Derivate als Riech- und/oder Aromastoffe |
| JP6073939B2 (ja) * | 2015-01-27 | 2017-02-01 | ちえ子 前田 | 外綴組み合わせファイル |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3551456A (en) * | 1968-04-18 | 1970-12-29 | Universal Oil Prod Co | Acetyl derivatives of substituted chromans and coumarans |
| JPS6031829B2 (ja) * | 1975-06-26 | 1985-07-24 | ウェルファイド株式会社 | アミノアルコ−ル誘導体の製造法 |
| FR2332010A1 (fr) * | 1975-11-18 | 1977-06-17 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
| FR2370472A2 (fr) * | 1976-11-10 | 1978-06-09 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
| CH615031A5 (pt) * | 1976-04-30 | 1979-12-28 | Gretag Ag | |
| JPS6019305B2 (ja) * | 1976-07-02 | 1985-05-15 | ウェルファイド株式会社 | ジヒドロベンゾフラン誘導体 |
| JPS603305B2 (ja) * | 1976-12-27 | 1985-01-26 | エーザイ株式会社 | ２，３―ジハイドロベンゾフラン誘導体 |
| US4130666A (en) * | 1977-05-16 | 1978-12-19 | Riker Laboratories, Inc. | Anti-inflammatory method |
| IT1093805B (it) * | 1978-01-31 | 1985-07-26 | Erba Carlo Spa | Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione |
| EP0026593A1 (en) * | 1979-09-15 | 1981-04-08 | Pfizer Limited | Bicyclic keto- and amino- acids, esters and amides and pharmaceutical compositions thereof |
| GR81257B (pt) * | 1982-12-04 | 1984-12-11 | Lilly Industries Ltd | |
| EP0117675B1 (en) * | 1983-02-19 | 1986-07-23 | Beecham Group Plc | Benzofuran and benzothiophene-carboxylic-acid derivatives |
| FI842738A7 (fi) * | 1983-07-14 | 1985-01-15 | Syntex Inc | Aroyylibentsofuraani- ja bentsotiofeenietikka- ja propionihapot. |
| US4613611A (en) * | 1983-10-14 | 1986-09-23 | American Cyanamid Company | Method of treating diabetes mellitus using arylglyoxals |
| AU4261285A (en) * | 1984-06-01 | 1985-12-05 | Tokyo Tanabe Company Limited | 1-propanone derivatives |
| US4708966A (en) * | 1986-06-27 | 1987-11-24 | The Procter & Gamble Company | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
| FR2613365B1 (fr) * | 1987-04-01 | 1989-07-28 | Adir | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2613364B1 (fr) * | 1987-04-01 | 1989-06-09 | Adir | Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| US4849428A (en) * | 1987-11-23 | 1989-07-18 | The Procter & Gamble Company | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use |
| US4982006A (en) * | 1987-12-18 | 1991-01-01 | Norwich Eaton Pharmaceuticals, Inc. | Process for the preparation of certain substituted aromatic compounds |
| IL88674A0 (en) * | 1987-12-18 | 1989-07-31 | Norwich Eaton Pharma | Preparation of certain substituted aromatic compounds |
| JPH07121933B2 (ja) * | 1988-03-28 | 1995-12-25 | キッセイ薬品工業株式会社 | ジヒドロベンゾフラノン誘導体 |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| JP2808460B2 (ja) * | 1989-11-16 | 1998-10-08 | 大正製薬株式会社 | イミダゾール誘導体 |
| JPH03215485A (ja) * | 1990-01-11 | 1991-09-20 | Taisho Pharmaceut Co Ltd | ベンゾチエニルイミダゾール誘導体 |
| TW197435B (pt) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
| JPH06263733A (ja) * | 1993-01-14 | 1994-09-20 | Sankyo Co Ltd | ベンゼン誘導体 |
| NZ290080A (en) * | 1994-07-27 | 1999-04-29 | Procter & Gamble | Dihydrobenzo(thio)furan derivatives and pharmaceutical compositions |
| US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
-
1996
- 1996-02-01 US US08/595,086 patent/US5672620A/en not_active Expired - Fee Related
-
1997
- 1997-01-30 AT AT97904021T patent/ATE266652T1/de not_active IP Right Cessation
- 1997-01-30 CN CN97191976A patent/CN1120838C/zh not_active Expired - Fee Related
- 1997-01-30 CA CA002244196A patent/CA2244196C/en not_active Expired - Fee Related
- 1997-01-30 DK DK97904021T patent/DK0891346T3/da active
- 1997-01-30 AU AU18434/97A patent/AU730310B2/en not_active Ceased
- 1997-01-30 JP JP09527763A patent/JP3095425B2/ja not_active Expired - Fee Related
- 1997-01-30 KR KR1019980705952A patent/KR100322403B1/ko not_active Expired - Fee Related
- 1997-01-30 DE DE69729083T patent/DE69729083T2/de not_active Expired - Fee Related
- 1997-01-30 EP EP97904021A patent/EP0891346B1/en not_active Expired - Lifetime
- 1997-01-30 ES ES97904021T patent/ES2221034T3/es not_active Expired - Lifetime
- 1997-01-30 BR BR9707266A patent/BR9707266A/pt not_active Application Discontinuation
- 1997-01-30 WO PCT/US1997/001316 patent/WO1997028148A1/en not_active Ceased
-
1998
- 1998-07-31 NO NO983531A patent/NO983531L/no not_active Application Discontinuation
- 1998-08-03 MX MX9806252A patent/MX9806252A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983531D0 (no) | 1998-07-31 |
| DE69729083D1 (de) | 2004-06-17 |
| AU730310B2 (en) | 2001-03-01 |
| US5672620A (en) | 1997-09-30 |
| DK0891346T3 (da) | 2004-08-09 |
| CA2244196C (en) | 2003-09-23 |
| JPH11504347A (ja) | 1999-04-20 |
| AU1843497A (en) | 1997-08-22 |
| CN1120838C (zh) | 2003-09-10 |
| JP3095425B2 (ja) | 2000-10-03 |
| EP0891346B1 (en) | 2004-05-12 |
| KR19990082224A (ko) | 1999-11-25 |
| CN1210528A (zh) | 1999-03-10 |
| WO1997028148A1 (en) | 1997-08-07 |
| DE69729083T2 (de) | 2004-09-23 |
| EP0891346A1 (en) | 1999-01-20 |
| ES2221034T3 (es) | 2004-12-16 |
| KR100322403B1 (ko) | 2002-05-09 |
| ATE266652T1 (de) | 2004-05-15 |
| MX9806252A (es) | 1998-11-30 |
| NO983531L (no) | 1998-09-28 |
| CA2244196A1 (en) | 1997-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9707333A (pt) | Dihidrobenzofurano e compostos relacionados úteis como agentes antinflamatórios | |
| BR9508901A (pt) | Di-hidrobenzofurano e composto relacionados utilizáveis como agentes antiflamatórios | |
| BR9707250A (pt) | Dihidrobenzofurano e compostos correlatos úteis como agentes antiinflamatórios | |
| BR9707266A (pt) | Compostos dihidrobenzofurano úteis como agentes antiinflamatórios | |
| BR9709556A (pt) | Dihidrobenzopirano e compostos a ele relacionados úteis como agentes antiflamatórios | |
| BR9707321A (pt) | Dihidrobenzofurano e compostor correlatos úteis como agentes antinflamatórios | |
| ES2196301T3 (es) | Dihidrobenzofurano y compuestos relacionados utilizados como agentes anti-inflamatorios. | |
| MX9806247A (es) | Dihidrobenzofurano y compuestos relacionados utiles como agentes antiinflamatorios. | |
| CA2244245A1 (en) | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer |
Free format text: VANDERBILT UNIVERSITY (US) |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |